Annexin Pharmaceuticals AB (publ) (STO:ANNX)

Sweden flag Sweden · Delayed Price · Currency is SEK
17.30
-0.30 (-1.70%)
Jan 21, 2026, 2:10 PM CET
-64.26%
Market Cap124.24M
Revenue (ttm)n/a
Net Income (ttm)-38.73M
Shares Out7.06M
EPS (ttm)-6.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,175
Average Volume3,158
Open17.60
Previous Close17.60
Day's Range16.30 - 17.60
52-Week Range16.20 - 55.40
Beta0.21
RSI39.72
Earnings DateFeb 5, 2026

About STO:ANNX

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol ANNX
Full Company Profile

Financial Performance

Financial Statements